BOND Ready-to-Use (RTU) Primary Antibody Progesterone Receptor (16) , Novocastra Concentrated Liquid Mouse Monoclonal Antibody— 510(k) K183102
Substantially EquivalentLeica Biosystems Newcastle, Limited
FDA 510(k) clearance K183102 for BOND Ready-to-Use (RTU) Primary Antibody Progesterone Receptor (16) , Novocastra Concentrated Liquid Mouse Monoclonal Antibody, Substantially Equivalent on 2018-12-07. Applicant: Leica Biosystems Newcastle, Limited.
Clearance details
- Applicant
- Leica Biosystems Newcastle, Limited
- Product code
- Code MXZ
- Advisory panel
- Hematology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Newcastle Upon Tyne, GB
Data sourced from openFDA. This site is unofficial and independent of the FDA.